• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症与炎症中的细胞焦亡和炎性小体

Pyroptosis and inflammasomes in cancer and inflammation.

作者信息

Wang Jie-Lin, Hua Sheng-Ni, Bao Hai-Juan, Yuan Jing, Zhao Yang, Chen Shuo

机构信息

Department of Obstetrics and Gynecology Guangzhou Key Laboratory of Targeted Therapy for Gynecologic Oncology Guangdong Provincial Key Laboratory of Major Obstetric Diseases The Third Affiliated Hospital of Guangzhou Medical University Guangzhou China.

Department of Gynecologic Oncology Research Office Guangzhou Key Laboratory of Targeted Therapy for Gynecologic Oncology Guangdong Provincial Key Laboratory of Major Obstetric Diseases The Third Affiliated Hospital of Guangzhou Medical University Guangzhou China.

出版信息

MedComm (2020). 2023 Sep 24;4(5):e374. doi: 10.1002/mco2.374. eCollection 2023 Oct.

DOI:10.1002/mco2.374
PMID:37752941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10518439/
Abstract

Nonprogrammed cell death (NPCD) and programmed cell death (PCD) are two types of cell death. Cell death is significantly linked to tumor development, medication resistance, cancer recurrence, and metastatic dissemination. Therefore, a comprehensive understanding of cell death is essential for the treatment of cancer. Pyroptosis is a kind of PCD distinct from autophagy and apoptosis in terms of the structure and function of cells. The defining features of pyroptosis include the release of an inflammatory cascade reaction and the expulsion of lysosomes, inflammatory mediators, and other cellular substances from within the cell. Additionally, it displays variations in osmotic pressure both within and outside the cell. Pyroptosis, as evidenced by a growing body of research, is critical for controlling the development of inflammatory diseases and cancer. In this paper, we reviewed the current level of knowledge on the mechanism of pyroptosis and inflammasomes and their connection to cancer and inflammatory diseases. This article presents a theoretical framework for investigating the potential of therapeutic targets in cancer and inflammatory diseases, overcoming medication resistance, establishing nanomedicines associated with pyroptosis, and developing risk prediction models in refractory cancer. Given the link between pyroptosis and the emergence of cancer and inflammatory diseases, pyroptosis-targeted treatments may be a cutting-edge treatment strategy.

摘要

非程序性细胞死亡(NPCD)和程序性细胞死亡(PCD)是两种细胞死亡类型。细胞死亡与肿瘤发展、耐药性、癌症复发和转移扩散密切相关。因此,全面了解细胞死亡对于癌症治疗至关重要。细胞焦亡是一种程序性细胞死亡,在细胞结构和功能方面有别于自噬和凋亡。细胞焦亡的决定性特征包括炎症级联反应的释放以及溶酶体、炎症介质和其他细胞内物质从细胞内排出。此外,它在细胞内外均表现出渗透压变化。越来越多的研究表明,细胞焦亡对于控制炎症性疾病和癌症的发展至关重要。在本文中,我们综述了目前关于细胞焦亡和炎性小体机制及其与癌症和炎症性疾病联系的知识水平。本文提出了一个理论框架,用于研究癌症和炎症性疾病中治疗靶点的潜力、克服耐药性、建立与细胞焦亡相关的纳米药物以及开发难治性癌症的风险预测模型。鉴于细胞焦亡与癌症和炎症性疾病发生之间的联系,靶向细胞焦亡的治疗可能是一种前沿的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce20/10518439/5fdb8afbd08d/MCO2-4-e374-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce20/10518439/ac364f90ed8b/MCO2-4-e374-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce20/10518439/9146826ecd4c/MCO2-4-e374-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce20/10518439/da95fc2be74e/MCO2-4-e374-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce20/10518439/5fdb8afbd08d/MCO2-4-e374-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce20/10518439/ac364f90ed8b/MCO2-4-e374-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce20/10518439/9146826ecd4c/MCO2-4-e374-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce20/10518439/da95fc2be74e/MCO2-4-e374-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce20/10518439/5fdb8afbd08d/MCO2-4-e374-g002.jpg

相似文献

1
Pyroptosis and inflammasomes in cancer and inflammation.癌症与炎症中的细胞焦亡和炎性小体
MedComm (2020). 2023 Sep 24;4(5):e374. doi: 10.1002/mco2.374. eCollection 2023 Oct.
2
Pyroptosis as a double-edged sword: The pathogenic and therapeutic roles in inflammatory diseases and cancers.细胞焦亡作为一把双刃剑:在炎症性疾病和癌症中的致病及治疗作用
Life Sci. 2023 Apr 1;318:121498. doi: 10.1016/j.lfs.2023.121498. Epub 2023 Feb 11.
3
Inflammasome-associated cell death: Pyroptosis, apoptosis, and physiological implications.炎症小体相关细胞死亡:细胞焦亡、细胞凋亡与生理意义。
Microbiol Immunol. 2020 Apr;64(4):252-269. doi: 10.1111/1348-0421.12771. Epub 2020 Jan 31.
4
NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy.NLRP3 炎性小体/细胞焦亡:糖尿病心肌病的关键驱动因素。
Int J Mol Sci. 2022 Sep 13;23(18):10632. doi: 10.3390/ijms231810632.
5
Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases.聚焦细胞焦亡:在眼部疾病发病机制和治疗潜力中的作用。
J Neuroinflammation. 2022 Jul 14;19(1):183. doi: 10.1186/s12974-022-02547-2.
6
[Development of Anti-inflammatory Drugs with Novel Mechanisms of Action Targeting Pyroptosis].[开发具有靶向细胞焦亡新作用机制的抗炎药物]
Yakugaku Zasshi. 2023;143(12):997-1003. doi: 10.1248/yakushi.23-00135.
7
Pyroptosis: A possible link between obesity-related inflammation and inflammatory diseases.细胞焦亡:肥胖相关炎症与炎症性疾病之间的潜在联系。
J Cell Physiol. 2022 Feb;237(2):1245-1265. doi: 10.1002/jcp.30627. Epub 2021 Nov 8.
8
Exploring the correlation between innate immune activation of inflammasome and regulation of pyroptosis after intracerebral hemorrhage: From mechanism to treatment.探讨脑出血后先天免疫激活炎性体与细胞焦亡调控的相关性:从机制到治疗。
Biomed Pharmacother. 2024 Oct;179:117382. doi: 10.1016/j.biopha.2024.117382. Epub 2024 Sep 5.
9
Role of Pyroptosis in Gynecological Oncology and Its Therapeutic Regulation.细胞焦亡在妇科肿瘤学中的作用及其治疗调控。
Biomolecules. 2022 Jul 1;12(7):924. doi: 10.3390/biom12070924.
10
Pyroptosis-based nanotherapeutics: Possible mechanisms for cancer treatment.基于细胞焦亡的纳米治疗学:癌症治疗的可能机制。
Life Sci. 2022 Nov 1;308:120970. doi: 10.1016/j.lfs.2022.120970. Epub 2022 Sep 14.

引用本文的文献

1
Is pyroptosis a brake or an accelerator in the fate of the tumor?细胞焦亡在肿瘤命运中是制动器还是加速器?
Cell Death Dis. 2025 Jul 28;16(1):568. doi: 10.1038/s41419-025-07866-9.
2
Tanshinone IIA reduces tubulointerstitial fibrosis by suppressing GSDMD-mediated pyroptosis.丹参酮IIA通过抑制Gasdermin D介导的细胞焦亡减轻肾小管间质纤维化。
Pharm Biol. 2025 Dec;63(1):364-373. doi: 10.1080/13880209.2025.2498166. Epub 2025 May 7.
3
The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases.中性粒细胞胞外诱捕网在自身免疫性疾病和自身炎症性疾病中的新作用。

本文引用的文献

1
A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation.RRx-001 综述:一种晚期多适应症 NLRP3 激活和慢性炎症抑制剂。
Drugs. 2023 Apr;83(5):389-402. doi: 10.1007/s40265-023-01838-z. Epub 2023 Mar 15.
2
Promoting GSDME expression through DNA demethylation to increase chemosensitivity of breast cancer MCF-7 / Taxol cells.通过 DNA 去甲基化促进 GSDME 表达以增加乳腺癌 MCF-7/Taxol 细胞的化疗敏感性。
PLoS One. 2023 Mar 3;18(3):e0282244. doi: 10.1371/journal.pone.0282244. eCollection 2023.
3
Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
MedComm (2020). 2025 Mar 6;6(3):e70101. doi: 10.1002/mco2.70101. eCollection 2025 Mar.
4
Loading of CAR-T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism.用磁性纳米颗粒加载CAR-T细胞以实现可控靶向,可抑制炎性细胞因子释放并改变肿瘤细胞死亡机制。
MedComm (2020). 2025 Jan 5;6(1):e70039. doi: 10.1002/mco2.70039. eCollection 2025 Jan.
5
The role of pyroptosis in cancer: key components and therapeutic potential.细胞焦亡在癌症中的作用:关键成分与治疗潜力。
Cell Commun Signal. 2024 Nov 15;22(1):548. doi: 10.1186/s12964-024-01932-z.
6
Poria cocos: traditional uses, triterpenoid components and their renoprotective pharmacology.茯苓:传统用途、三萜类成分及其肾脏保护药理学。
Acta Pharmacol Sin. 2025 Apr;46(4):836-851. doi: 10.1038/s41401-024-01404-7. Epub 2024 Oct 31.
7
Cell death pathways: molecular mechanisms and therapeutic targets for cancer.细胞死亡途径:癌症的分子机制与治疗靶点
MedComm (2020). 2024 Sep 4;5(9):e693. doi: 10.1002/mco2.693. eCollection 2024 Sep.
8
Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21-activated kinase 4.靶向RAC1通过抑制p21活化激酶4来重新激活细胞焦亡,从而逆转卵巢癌对紫杉醇的耐药性。
MedComm (2020). 2024 Sep 2;5(9):e719. doi: 10.1002/mco2.719. eCollection 2024 Sep.
9
To Establish a Nomogram Prediction of Prostate Cancer Based on Pyroptosis-Related Genes that Affect the Immune Microenvironment.基于影响免疫微环境的焦亡相关基因建立前列腺癌预测列线图。
Asian Pac J Cancer Prev. 2024 Jul 1;25(7):2319-2327. doi: 10.31557/APJCP.2024.25.7.2319.
10
Pyroptosis, gasdermins and allergic diseases.细胞焦亡、gasdermin 家族蛋白与变应性疾病
Allergy. 2024 Sep;79(9):2380-2395. doi: 10.1111/all.16236. Epub 2024 Jul 14.
鉴定和验证卵巢癌预后和免疫治疗中的焦亡相关基因图谱。
J Ovarian Res. 2023 Jan 27;16(1):27. doi: 10.1186/s13048-022-01065-2.
4
A Dual-Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis.一种双响应性 STAT3 抑制剂纳米前药联合溶瘤病毒通过引发细胞焦亡激发协同抗肿瘤免疫反应。
Adv Mater. 2023 Mar;35(11):e2209379. doi: 10.1002/adma.202209379. Epub 2023 Feb 3.
5
Characteristics of gastric cancer around the world.世界各地胃癌的特征。
Crit Rev Oncol Hematol. 2023 Jan;181:103841. doi: 10.1016/j.critrevonc.2022.103841. Epub 2022 Oct 11.
6
Lower expression of NINJ1 (Ninjurin 1), a mediator of plasma membrane rupture, is associated with advanced disease and worse prognosis in serous ovarian cancer.NINJ1(神经损伤诱导蛋白1)是质膜破裂的介质,其低表达与浆液性卵巢癌的疾病进展和较差预后相关。
Immunol Res. 2023 Feb;71(1):15-28. doi: 10.1007/s12026-022-09323-7. Epub 2022 Oct 3.
7
BI 2536 induces gasdermin E-dependent pyroptosis in ovarian cancer.BI 2536可诱导卵巢癌中gasdermin E依赖性细胞焦亡。
Front Oncol. 2022 Aug 9;12:963928. doi: 10.3389/fonc.2022.963928. eCollection 2022.
8
Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor Cells.电离辐射通过诱导肿瘤细胞中gasdermin E介导的细胞焦亡触发抗肿瘤免疫。
Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):440-452. doi: 10.1016/j.ijrobp.2022.07.1841. Epub 2022 Jul 30.
9
A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC).2022年广泛期小细胞肺癌(SCLC)最新进展
J Cancer. 2022 Jul 18;13(9):2945-2953. doi: 10.7150/jca.75622. eCollection 2022.
10
[IL-1β inhibitor sensitizes to olaparib in homologous recombination deficiency proficient ovarian cancer cells].[白细胞介素-1β抑制剂使同源重组缺陷 proficient 卵巢癌细胞对奥拉帕尼敏感] (这里原文中的“proficient”可能有误,若为“deficient”,则整句更通顺合理,即:[白细胞介素-1β抑制剂使同源重组缺陷的卵巢癌细胞对奥拉帕尼敏感] )
Zhonghua Fu Chan Ke Za Zhi. 2022 Jul 25;57(7):519-529. doi: 10.3760/cma.j.cn112141-20220509-00307.